In zebrafish, maternally produced vasa (vas) transcripts become targeted to the cleavage planes of early embryos and subsequently incorporated into the primordial germ cells (PGCs). Zygotic vas transcription occurs from the onset of gastrulation. Here, we report on the characterisation of the zebrafish vas locus. The gene consists of 27 exons, spans about 25 kb, and contains two CpG-rich regions. We have used vas regulatory regions to establish transgenic zebrafish lines expressing enhanced green fluorescent protein (EGFP) in their PGCs. Maternally encoded vas::EGFP transcripts and VAS::EGFP protein segregate with the PGCs during embryogenesis. We find that the maternally deposited vas::EGFP transcripts are stable during embryogensis at least up to 50 h of development. Vas::EGFP transcripts could not be detected in embryos that inherit the transgene from males, most likely due to the lack of one or more regulatory elements required for early zygotic expression. We show that vas::EGFP transcripts become enriched to the cleavage planes in early embryos, a finding that supported an RNA localisation signal localised within the vas region of these transcripts. q
Introduction
In many organisms, primordial germ cells (PGCs) are established during early ontogeny under the control of maternal factors (reviewed in Saffman and Lasko, 1999; Williamson and Lehmann, 1996; Wylie, 1999) . These factors have been best characterised in Drosophila melanogaster and Caenorhabditis elegans where some of them have been shown to be components of germ granules, cytoplasmic particles that form during oogenesis and that segregate with the germ cell lineage (Breitwieser et al., 1996; Gruidl et al., 1996; Hay et al., 1988; Kawasaki et al., 1998) . A characteristic feature of the known protein components of the C. elegans germ granules is that they all appear to contain RNA-binding motifs (Seydoux and Strome, 1999) . On this basis, it has been proposed that the germ granules contain or interact with RNA. Similar structures, referred to as nuage, have been found in the germ line of other species, including vertebrates (Eddy, 1975) . Although it has been speculated that the germ granules function as scaffolds for transporting and delivering germ cell determinants, their role in germ cell establishment remains to be determined.
The first germ granule component to be identified was the Drosophila protein VASA (VAS), a DEAD box RNA helicase that serves as a marker for the developing germ line (Hay et al., 1988) . Mutations in the vasa (vas) gene abolish germ cell development and, since vas is a maternal effect gene, mutant females produce embryos that lack germ granules and PGCs (Schupbach and Wieschaus, 1986) . The VAS protein appears to be involved in translational regulation of mRNAs like oskar and gurken (Styhler et al., 1998; Tomancak et al., 1998) . Furthermore, VAS protein has been shown to interact with the Drosophila homologue of the initiation factor dIF2, a finding that links this protein to translational regulation (Carrera et al., 2000) . Recently, vertebrate homologues of vas have been identified and shown to display a germ cell specific expression pattern (reviewed in Raz, 2000) . Vas transcripts and VAS protein have been found in close proximity to structures resembling germ granules in zebrafish and chicken, respectively (Knaut et al., 2000; Tsunekawa et al., 2000) . Furthermore, knock-out mice lacking vas function fail to form sperm (Tanaka et al., 2000) . VAS may therefore be a part of a conserved pathway controlling germ cell development in both invertebrates and vertebrates.
In zebrafish, the germ-soma segregation is completed by the onset of the sphere stage resulting in the formation of four PGCs, a process that can be monitored by following the pattern of maternal vas transcripts (Olsen et al., 1997; Yoon et al., 1997; Knaut et al., 2000) . Subsequently, the four vaspositive cells start to divide, migrate and by the early segmentation period they combine to form two clusters of PGCs located laterally to somites 3-5 (Olsen et al., 1997; Yoon et al., 1997) . Each cluster consists of 15-20 cells. Shortly after the beginning of the pharyngula period, the PGCs extend into two rows of cells positioned along the gut.
We have adopted transgene technology to further explore the role of vas in the development of the PGCs with the long-term goal of isolating pure populations of PGCs. To this end, we have cloned the vas locus, isolated its regulatory regions, and used these to generate transgenic zebrafish lines expressing enhanced green fluorescent protein (EGFP) in their PGCs. We further show that these vas::EGFP transgenic lines can be used to identify vas cis-elements which are involved in the subcellular localisation of vas mRNA.
Results

Isolation and characterisation of genomic zebrafish vas clones and identification of a putative promoter region
To clone the zebrafish vas locus, including its regulatory regions, a hybridisation screen of a genomic zebrafish lEMBL SP6/T7 library was performed using a vas cDNA fragment as a probe. We isolated three overlapping genomic vas clones from the phage library and these clones were sequenced (EMBL Accession no: AJ311625). Analysis of these clones and a comparison with the previously identified cDNAs show that the zebrafish locus spans approximately 25 kb and the gene consists of 27 exons varying in size from 27 to 729 nt (Fig. 1A) . We have identified a putative core promoter containing both a TATA box and a potential transcription initiator element (Fig. 1B) . The 5 0 untranslated region (5 0 UTR) is situated in a CpG-rich region, whereas
another CpG-rich region is located within the third intron of the locus. Both CpG-rich regions are about 500 bp long. Silencing of genes by methylation of CpG islands is known to occur in mammals (Razin and Riggs, 1980) . The finding that the vas locus contains CpG regions indicates that methylation may also play a role in the regulation of zebrafish vas expression. Thus, we decided to include the region encompassing both CpG regions in the vas::EGFP transgene construct as described below.
Construction and evaluation of the vas::EGFP transgene vector
Construct pK4 contains an 8.5 kb fragment upstream of codon 25 of vas fused in frame with the reporter gene EGFP. In addition, a 2.3 kb fragment containing the 3 0 UTR and 1.7 kb of downstream sequences was fused to the 3 0 end of EGFP (Fig. 1 ). This construct was microinjected into one-cell stage zebrafish embryos. These embryos were then raised and examined for the transient expression of the reporter gene at defined developmental stages. By fluorescence microscopy, EGFP-positive cells were observed in 50-80% of the embryos from the onset of the segmentation period. Immunostaining of zebrafish embryos using an anti-GFP antiserum revealed that EGFP-positive cells are indeed located at the same regions known to contain the PGCs ( Fig. 2A) . Recently, it was shown that nanos (nos) is expressed in the PGCs of zebrafish (Koprun- ). Here we use double fluorescence whole mount in situ analysis, to detect vas::EGFP transcripts in nos expressing cells (Fig. 2B, C) . As summarised in Table 1 , approximately 22% of the injected embryos showed ectopic expression as well as expression of vas::EGFP in nos fluorescent cells. In these transient expression studies, the number of vas::EGFP positive PGCs ranged from one to five in different embryos. These data therefore suggest that the regulatory regions included in construct pK4 are sufficient to direct germ cell specific expression of EGFP during embryogenesis. This expression of the vas::EGFP construct is zygotic. Early expression of the vas::EGFP construct after their injection into zebrafish eggs is most likely deriving from un-integrated copies of the construct.
Establishment of transgenic zebrafish lines expressing EGFP in their PGCs
The injected embryos were raised to sexual maturity and F 0 adult crosses performed. Genomic polymerase chain reaction (PCR) combined with fluorescence microscopy was used to identify transgenic progeny. Out of 256 F 0 adult fish, two males and four females, were found to transmit the transgene to the F 1 generation.
To determine the expression profile of the transgene, transgenic founder females were mated with wild-type males and the resulting embryos examined by fluorescence microscopy. Depending upon which founder females were chosen, approximately 5-20% of the embryos expressed EGFP in all blastomeres up to the shield stage of development (Fig. 3, panels A-D) . This expression pattern is reminiscent of the maternal VAS protein pattern during early zebrafish ontogeny (Braat et al., 2000; Knaut et al., 2000) . From the early segmentation period onwards, two clusters of EGPF-positive cells located laterally to the paraxial mesoderm were also identified (Fig. 3 , panel E). These cells are most likely the PGCs and are hereafter referred to as PGCs. Although EGFP-positive PGCs can be detected as early at the fifth somite stage, EGFP was still present in somatic tissues. EGFP in somatic cells gradually disappeared and was eventually restricted to the PGCs (see Fig. 3 , panels E-H). At the onset of the pharyngula stage, the EGFP-positive cells form two lateral rows of cells (Fig. 3, panel F) .
EGFP-positive PGCs have also been detected after hatching (Fig. 3 , panels G-H).
When heterozygous F 1 or F 2 females harbouring the vas::EGFP transgene were crossed with non-transgenic (64) 27% (36) a Injected embryos were examined for the expression of vas::EGFP and nos transcripts at the late segmentation, early pharyngula stage by double fluorescence whole mount in situ analysis.
b vas::EGFP expressing and non-expressing embryos were scored (numbers shown in parenthesis). c Cells showing co-expression of vas::EGFP and nos transcripts were scored as PGCs. males all the resulting embryos displayed the EGFP pattern as shown in Fig. 3 (panels A-F). This is most likely due to the fact that vas::EGFP transcripts and protein synthesised during oogenesis in F 1 and F 2 females also become stored in oocytes developing as non-transgenic oocytes. In this case, both non-trangenic and transgenic embryos will contain vas::EGFP transcripts and VAS::EGFP protein. If these maternally produced vas::EGFP transcripts and protein are very stable, they will continue to be present in developing non-transgenic embryos. Thus, individual F 2 and F 3 progeny were examined for the presence of the vas::EGFP transgene by PCR on genomic DNA isolated from 72 h old larvae (see Section 5). Since, as summarised in Table 2 , approximately 50% of the phenotypically positive progeny contained the transgene, the vas::EGFP transgene is most likely integrated at a single locus and stably transmitted to the progeny in a Mendelian fashion. Multiple integrations at different chromosomes would have resulted in a higher frequency.
Absence of VAS::EGFP protein during zebrafish embryogenesis following male transmission of the transgene
In zebrafish, initiation of zygotic transcription occurs around the midblastula stage of development (Kane and Kimmel, 1993) . Zygotic activation of the vas::EGFP transgene during embryogenesis can be determined by following the activation of the paternal transgene locus. To obtain progeny hemizygous for the vas::EGFP transgene, transgenic founder males or F 1 males from three different lines were mated with non-transgenic females. The resulting embryos were evaluated by fluorescence microscopy, reverse transcriptase-polymerase chain reaction (RT-PCR) and whole-mount in situ analyses. Although germ line transmission of the vas::EGFP transgene was confirmed by PCR, none of these embryos, contained green fluorescent cells. By RT-PCR, no amplification products of vas::EGFP transcripts were obtained from embryos geno-typed as transgenic (see Fig. 4A ). Furthermore, whole-mount in situ 
a Matings were set up with heterozygous transgenic females and wildtype males. Females from two different lines, line A and B, were used. Numbers 1-3 refer to different females from a given line.
b Phenotypic analysis was performed by fluorescence microscopy, and all embryos checked for the presence of fluorescent VAS::EGFP protein in their PGCs.
c Genotypic analysis was performed by PCR. N refers to the total number of embryos analysed. Genomic DNA and total RNA isolated from individual 24 h embryos obtained from a transgenic male/wild-type female cross served as template for the genomic PCR (panel 1) and reverse transcription (panels 2 and 3), respectively. Genomic DNA and total RNA isolated from a transgenic embryo obtained from a transgenic female/wild-type male served as a PCR control (lane C). In panel 1, the arrow and the star point to the 410 bp EGFP fragment and the 310 bp vas fragment amplified by the primers EGFP3(1)/EGFP2(2) and v-GRHL(1)//vasP3(2), respectively. In panels 2 and 3, detection of vas and vas::EGFP transcripts is monitored by RT-PCR. Reverse transcription was carried out with the primer vas39(2) recognising the common 3 0 UTR of vas::EGFP and vas transcripts. A semi-nested PCR was performed with the primers vas7(1)/vasP3(2) and v-GRHL(1)/vasP3(2) to detect a 200 bp fragment of the vas cDNA (panel 2), whereas a rePCR was performed with the primers vas15(1)/GFP2(2) to amplify a 720 bp region of the vas::EGFP cDNA (panel 3). M contains the 100 bp ladder molecular size marker. (B) Detection of VAS::EGFP protein following female transmission of the transgene. All crosses were performed with wild-type zebrafish and transgenic zebrafish of the opposite sex. Transgenic zebrafish is indicated by striped symbols. Females, males and embryos are depicted by circles, squares, and triangles, respectively. The pheno-type of the embryos obtained from these transgenic/wild-type crosses was determined by fluorescence microscopy. Embryos loaded with green fluorescent protein are depicted by green symbols. (Note: The question mark indicates that zygotic expression of the vas::EGFP transgene has to take place during female development) analysis on embryos obtained from such crosses, revealed no signal using a riboprobe specific to EGFP (data not shown). Thus, the above data suggest that the vas::EGFP transgene, when transmitted through males, is not expressed during embryogenesis.
To rule out the possibility that the transgene had been physically disrupted, we decided to test whether the transgene would be active when brought back into females. We therefore raised non-expressing transgenic embryos to adulthood, sorted the females from the males and used these females to produce new embryos (see Fig. 4B ). As monitored by fluorescence microscopy, all these embryos contain fluorescent PGCs during somitogenesis. Since EGFP is known to be stable for at least 24 hours, the fluorescent protein detected in the PGCs during somitogenesis is most likely synthesised from maternal vas::EGFP transcripts produced during oogenesis. Since Knaut et al. (2000) detect zygotic vas expression in Danio rerio/Danio feegradei hybrids from the onset of gastrulation, one interpretation of our findings is that the vas::EGFP transgene lacks regulatory elements necessary for recapitulating the early zygotic expression pattern of the endogenous vas gene. The zygotic expression observed with our vas::EGFP construct in transient expression studies may therefore be explained by a weak zygotic activity that is revealed when the construct is present in multiple copies as in these experiments.
Localisation of vas::EGFP transcripts to the cleavage plane
To determine the spatial distribution of vas::EGFP transcripts during zebrafish development, we performed wholemount RNA in situ analysis using a riboprobe specific for EGFP on embryos inheriting the transgene from females. All embryos, including non-transgenic and transgenic embryos, displayed a vas::EGFP distribution profile as shown in Fig. 5 . Thus, non-transgenic embryos resulting from transgenic female/wild-type male crosses are loaded with maternally produced vas::EGFP transcripts which segregate with the PGCs during subsequent development. As shown in Fig. 5 (panels A-B) , maternally deposited vas::EGFP transcripts are enriched to the cleavage plane of 2 and 4 cell stage embryos, a pattern very similar to the vas pattern reported by Yoon et al. (1997) . These data suggest that an RNA localisation signal is present within the vas::EGFP transgene. At 50% epiboly, four clusters of vas::EGFP positive cells were identified, cells most likely representing PGCs. In addition, a much weaker staining was observed in all the blastomeres of young embryos, similar to the pattern described by Olsen et al. (1997) . These transcripts might be the source of the fluorescent protein observed in the somatic blastomeres of young zebrafish embryos (compare Figs. 3 and 5) . Furthermore, two clusters of PGCs were detected from the onset of somitogenesis (Fig. 5). 2.6. Maternally deposited vas::EGFP transcripts appear to be stable during zebrafish embryogenesis Non-transgenic embryos resulting from a transgenic female/wild-type male cross contain maternally deposited vas::EGFP transcripts. As development proceeds, we Genomic DNA and total RNA isolated from indivual 48 h old F 2 progeny (lanes 1-6) served as template for the genomic PCR (panel 1) and reverse transcription (panels 2 and 3), respectively. The same pairs of primers were used as in Fig. 4 . Genomic DNA and total RNA isolated from a single wildtype progeny served as a PCR control (lane C). In panel 1, the arrow and the star point to the amplified EGFP fragment of the transgene and the amplified vas fragment of the endogenous vas gene, respectively. In panels 2 and 3, detection of vas and vas::EGFP transcripts was monitored by RT-PCR. M contains the 100 bp ladder molecular size marker. expect such transcripts to become degraded and eliminated from the non-transgenic animals. By RT-PCR we were able to amplify spliced vas::EGFP transcripts from 48 h old embryos geno-typed by PCR to be non-transgenic (Fig. 6) . Furthermore, our whole-mount in situ analysis indicates that maternally produced vas::EGFP transcripts are still present in the PGCs of 50 h old non-transgenic embryos (see Fig.  5F ). These data suggest that maternally synthesised vas::EGFP transcripts are exceptionally stable.
Discussion
PGCs become established during early animal development. vas transcripts serve as a marker for the developing germ line in the zebrafish (Olsen et al., 1997; Yoon et al., 1997) . In this organism, germ-soma segregation appears to be completed by the onset of early gastrulation, an event which can be monitored by following the segregation of maternally deposited vas transcripts (Olsen et al., 1997; Yoon et al., 1997) .
A vas::EGFP transgene can be used to fluorescently tag the PGCs
The results presented here demonstrate that the vas::EGFP transgene contains regulatory elements sufficient for driving stable EGFP expression during oogenesis. Maternally deposited vas::EGFP transcripts and protein segregate with the PGCs during embryogenesis.
Two recent reports have shown transgene expression in trout and medaka PGCs using regulatory regions of the vas gene fused to EGFP (Tanaka et al., 2001; Yoshizaki et al., 2000) . The structural organisation of the trout and the medaka vas::EGFP constructs are very similar. The reporter gene is flanked by a 5 0 region of the vas gene which spans a 3.3 kb promoter region fragment and the first two exons of vas. In addition, the 3 0 UTR of the medaka vas and a region spanning the 3 0 UTR and a 1.3 kb downstream flanking region of the trout vas was included in these constructs, respectively. In the construct used here, the EGFP is flanked both by a 8.5 kb 5 0 and a 2.3 kb 3 0 fragment of the zebrafish vas gene (see Fig. 1 ). The 5 0 fragment includes a 2.4 kb promoter fragment and transcribed sequences, including the first three introns, down to codon 25 of vas, whereas the 3 0 fragment contains the 3 0 UTR and a 1.7 kb fragment from the downstream flanking region. Since the nucleotide sequences of the medaka and the trout vas have not been made available, sequence analysis to search for potential conserved sequence motifs within their 5 0 flanking regions and the zebrafish gene is not possible. Furthermore, the organisation of the 5 0 region of the zebrafish vas is different from the trout and the medaka vas. Both the trout and the medaka gene contain a relatively large first intron in their 5 0 UTRs, whereas the zebrafish gene contains a small first intron. The zebrafish vas has a large third intron which contains a CpG-rich motif whereas another CpG region is situated in the 5 0 UTR of the zebrafish gene. Since DNA methylation has been reported to influence gene expression (for a review, see Ng and Bird, 1999) , we included the region containing these CpG-rich motifs in our vas::EGFP construct. Although we can monitor EGFP in somatic cells and PGCs during zebrafish embryogenesis (see Fig. 3 ), RT-PCR and whole-mount in situ analyses revealed that the vas::EGFP transgene is not expressed during embryogenesis after being passed through the germ line of males. Since non-transgenic embryos descending from transgenic females also contain EGFP in somatic tissue and their PGCs during embryogenesis and early larval development, the fluorescent protein observed during this period must be of maternal origin or derive from the translation of maternally provided vas::EGFP mRNA. The EGFP protein is known to be stable for at least 24 h. Furthermore, we have not been able to observe a difference in the fluorescent signal in the population of progeny containing EGFP positive PGCs during the first 5 days of development. Although we do not know exactly at which time during zebrafish development the vas::EGFP transgene is turned on, our results are consistent with the activation of the isolated vas promoter during oogenesis. We have been able to follow fluorescently tagged PGCs for at least 3 weeks. Lack of zygotic expression during embryogenesis may be due to absence of regulatory elements from the transgene. An alternative explanation may be that more than one promoter exists, one which is active during embryogenesis and another, which is active during oogenesis. If this is correct, then our observation of transient zygotic expression from the vas::EGFP construct may be explained by the presence of multiple and unintegrated copies.
Our inability to demonstrate zygotic vas transcripts during embryogenesis may alternatively be explained by vas being transcribed only during gametogenesis. A recent study by Knaut et al. (2000) makes this, however, unlikely. They generated hybrid embryos from D. rerio females and D. feegradei males and found that the paternal vas allele was expressed from the late sphere stage of development and onwards. Furthermore, Tanaka et al. (2001) showed that zygotic medaka vas::EGFP transcripts were present in 4-somite-stage embryos.
A role for RNA localisation signals in the transport of vas transcripts during zebrafish development
In our study, we have used zebrafish embryos hemizygous for either the maternal or the paternal vas::EGFP transgene. We have found that zebrafish embryos inheriting the transgene from females contain maternal vas::EGFP transcripts in their PGCs during embryogenesis. vas::EGFP transcripts were enriched to the cleavage plane of 2-and 4-cell stage embryos. A likely explanation for this finding is that the chimeric transcripts are recognised by the RNA transport machinery of these cells. Localisation of defined mRNAs to distinct cytoplasmic regions has been observed in a number of model systems and in several cases, the transport has been shown to be dependent on RNA localisation signals residing in the 3 0 UTRs (Ephrussi and Lehmann, 1992; Gavis et al., 1996) . Furthermore, such mRNAs are thought to be transported along the cytoskeleton as ribonucleo-protein particles. A role for the microtubuli in the translocation of vas transcripts along the forming cleavage furrow has been proposed (Pelegri et al., 1999) . In yeast, however, the actin-myosin system has been shown to be responsible for the transport of the Ash1-mRNA to the budding daughter cell (Takizawa et al., 1997; Takizawa and Vale, 2000) . Since the vas::EGFP transcripts contain both the 5 0 UTR, the 3 0 UTR as well as the first 25 codons of the vas, our data do not allow us to delimit the RNA localisation signal any further. Although vas::EGFP transcripts become transported to the cleavage plane, unlocalised transcripts were also detected in young embryos by whole-mount RNA in situ analysis. One possibility is that these transcripts become translated and give rise to the fluorescent protein detected throughout the blastomeres. Alternatively, the fluorescent protein results from translation before ovulation. The finding that EGFP is present in all blastomeres of young embryos is consistent with the observation that endogenous VAS protein is dispersed throughout the blastomeres at these developmental stages (Braat et al., 2000; Knaut et al., 2000) .
3.3. Is an RNA protection mechanism involved in regulating germ cell fate in the zebrafish?
In insects and amphibians, degradation of maternal transcripts is thought to be completed prior to the MBT (Bashirullah et al., 2001) . Two RNA degradation pathways operate to eliminate maternally deposited transcripts from the early Drosophila embryo (Bashirullah et al., 1999) . Although the RNA degradation machinery is found to be dispersed throughout the Drosophila embryo, a subset of RNAs is protected from degradation in the germ plasm/the pole cells (Bashirullah et al., 1999) . Among these maternally synthesised RNAs are nanos and Pgc, transcripts crucial for germ cell development Nakamura et al., 1996) . Since mutants lacking germ granules result in their elimination from the germ plasm, a role for the germ granules in transcript protection has been suggested (Bashirullah et al., 1999) . In this work we find that maternally synthesised vas::EGFP transcripts are present in non-transgenic zebrafish embryos derived from transgenic females. Since the transgene is absent from these embryos, it should now be possible to follow the fate of the maternally synthesised vas::EGFP transcripts during zebrafish embryogenesis. Our whole-mount in situ analysis shows that maternally produced vas::EGFP transcripts are still present in PGCs of 50 h old non-transgenic embryos. vas::EGFP transcripts are also detectable by RT-PCR in 48 h old non-transgenic embryos. Cis-acting elements essential for transcript degradation of nanos and Hsp73 have been mapped within their 3 0 -UTRs (Dahanukar and Wharton, 1996; Bashirullah et al., 1999; Smibert et al., 1999) . When in vitro synthesised Hsp73 transcripts containing a degradation element are injected into Xenopus oocytes, they are rapidly degraded (Bashirullah et al., 1999) . This is in contrast to transcripts lacking the degradation element. They remain easily detectable 24 h after injection. Similarly, the zebrafish vas::EGFP transcripts may also contain degradation elements. If so, our data may be explained by germ-line-specific factors acting on such elements protecting the transcripts from degradation in this cell lineage. Further studies will be required to elucidate the mechanism involved in stabilising maternal vas::EGFP transcripts in the PGCs.
Note
During the revision of this manuscript two publications have appeared that are consistent with our data. Knaut et al. (2002) used the maternally active elongation factor 1 a promoter of Xenopus to establish transgenic zebrafish lines expressing GFP in their PGCs. With these constructs they identified an element sufficient for mRNA localisation at the cleavage plane in 2-and 4-cell embryos. Wolke et al. (2002) used an RNA injection assay to follow the fate of in vitro synthesised chimeric vas-GFP transcripts in the developing zebrafish embryos and found that the injected transcripts are stabilised in the PGCs for up to 50 h of development.
Experimental procedures
Zebrafish were maintained and staged as described in Westerfield (1995) . For injection studies, the Tuebingen/ AB strain was used.
Isolation of genomic zebrafish vas clones
A lEMBL SP6/T7 genomic cDNA library (Clontech) was screened with an oligo vas cDNA fragment (nucleotides 1-640, accession number Y12007). Hybridisation was carried out at 688C according to the protocol of Church and Gilbert (1984) . Positive l clones were purified using LambdaSorbe Phage Adsorbent (Promega), digested with SacI and the genomic inserts subcloned into the SacI site of pBS(2) (Stratagene). Plasmid DNA was purified using Qiagen columns. All sequence reactions were performed using the ABI PRISMe Big Dye Terminator Cycle Ready Reaction Kit (Perkin Elmer) and analysed on an ABI PRISM 377-96 DNA sequencer. Sequence assembly was achieved using the gel assembly system of the GCG8 package (GCG8, 1994) . The genomic vas sequence has been deposited in the EMBL nucleotide sequence database with the accession number AJ311625. 
Primers
Preparation of the vas promoter construct pK4
A vas construct which contains the three first exons and introns plus the fourth exon down to codon 25 of vas fused in frame with the initiation codon of EGFP (Clontech) and a 2.3 kb fragment downstream of the stop codon of vas ligated to the 3 0 end of the reporter gene EGFP was generated as described below. Regulatory regions of the zebrafish vas were amplified by PCR from genomic DNA or genomic vas clones. Primers vas43(1)/vas42(2) which spans the promoter and 5 0 UTR region down to the initiation start codon of the zebrafish vas locus were used to amplify a 3.1 kb genomic vas fragment. PCR was performed using the Advantagee KlenTaq Polymerase Mix PCR system (Clontech). After the initial denaturation step, the PCR parameters were 30 cycles at 948C for 30 s, 508C for 30 s, 688C for 5 min. The resulting PCR product was digested with BamHI and NcoI and subcloned into the corresponding sites of pBS-EGFP to create pKa. Similarly, the 2.3 kb fragment 3 0 to the stop codon of the vas (VAS3) was amplified with the primers vas41(1)/ vas59(2) using the Expande Long Template PCR system (Roche). After the initial denaturation step, the PCR consisted of 25 cycles at 948C for 50 s, 508C for 50 s, 688C for 1.5 min. The 0.8 kb NotI/SacI fragment of the PCR product VAS3, containing the 3 0 UTR of vas, was inserted into pKa to create pKb. The 4.6 kb BamHI/SacI fragment of pKb, containing the vas promoter/EGFP/vas 3 0 UTR region, was then transferred to pGEM11zf(1) (Promega) to generate pKc. Subsequently, the 1.5 kb SacI fragment of the PCR product VAS3, containing 3 0 flanking sequences downstream of the 3 0 UTR of vas, was introduced into pKc to create pK3. To isolate the genomic 8.5 kb fragment upstream of codon number 25 of vas, PCR amplification was carried out with the primers vas67(1)/vas68(2) using the Expande Long Template PCR system (Roche). After the initial denaturation step, the PCR conditions were 20 cycles at 948C for 10 s, 588C for 30 s, 688C for 7 min, increasing the extension time with 20 s per cycle from cycle 11. This PCR product was digested with XbaI and NcoI resulting in a 8.2 kb XbaI/NcoI fragment and a 0.3 kb NcoI fragment, respectively. The 8.2 kb XbaI/NcoI fragment containing the promoter region replaced the 3.1 kb XbaI/NcoI fragment of pK3 to create pKd. Finally, the 0.3 kb NcoI fragment was introduced into the corresponding site of pKD and the resulting in frame vas::EGFP fusion plasmid was named pK4 (see Fig. 1 ).
Microinjection of the vas promoter construct in zebrafish embryos
The restriction endonucleases XbaI and SfiI were used to release the 11.5 kb vas::EGFP insert of pK4. DNA fragments were purified using the QIAEX II gel extraction kit (Qiagen). The purified DNA fragments were dissolved in 5 mM Tris-HCl pH 8.0, 200 mM KCl, 0.05% Phenol Red to a final concentration of 50 ng/ml and the construct injected into 1 cell stage zebrafish embryos using the Picospritzerw II microinjector (Parker Instrumentation).
Immunohistochemistry for detection of EGFP
Immunohistochemistry was performed as described by Drivenes et al. (2000) . The polyclonal GFP antibody (Clontech) and the peroxidase-conjugated swine secondary antibody against rabbit IgG (DAKO) were diluted to 1:2000 and 1:100, respectively. The staining reaction was carried out for 20-30 min.
Whole-mount RNA in situ hybridisation
Antisense and sense EGFP riboprobes were prepared using the digoxigenin (DIG) RNA labeling kit (Roche). Whole-mount in situ hybridisation was carried out essentially as described by Thisse et al. (1993) with the following modifications: preadsorption of the anti-DIG antibody and blocking were performed in the presence of PBT/2% Blocking Reagent (Roche). Levamisol (1 mM) was included during the final washing step prior to staining and during the subsequent staining step. For double fluorescence in situ hybridisation, fluorescein-labelled EGFP and DIG-labelled nos riboprobes were prepared using the Fluorescein and the DIG RNA labeling kit (Roche). The nos probe was synthesised from a region covering nucleotides 61-780 of the nos cDNA, accession number NM 131878. Nos transcripts were visualised with the alkaline phosphatase-conjugated anti-DIG antibody/FAST RED alkaline phosphatase system (Roche). The embryos were subsequently fixed in 4% PFA/PBT for 20 min, incubated with a HRP-conjugated anti-fluorescent antibody (NEN) at a 1:200 dilution. Visualisation of fluorescein-labelled EGFP probe was performed with the TSAe plus fluorescence system (NEN).
5.7. Reverse transcriptase polymerase chain reaction analysis of embryonic RNA Total RNA was isolated from individual zebrafish embryos using the Trizol reagent (GIBCO BRL). For the RT-PCR analysis, total RNA from both transgenic and wildtype embryos were used as templates for the first strand cDNA synthesis. The reverse transcription was primed with the vas specific primer vas39(2) and the first strand cDNA synthesis was carried out as described by Olsen et al. (1997) . A semi-nested PCR was performed with the primer pairs, vas7(1)/vasP3(2) and v-GRHL(1)/vasP3(2) to amplify a 200 bp region of the vas cDNA whereas a re-PCR was conducted with the primers vas15(1)/ EGFP2(2) to detect a 720 bp region of the vas::EGFP cDNA. PCR amplification was performed using the AmpliTaq Gold PCR system (Perkin Elmer). After the initial denaturation step, the PCR consisted of 30 cycles at 968C for 30 s, 508C for 30 s, 688C for 1.5 min.
Identification of transgenic fish by polymerase chain reaction
Genomic DNA was isolated from embryos as described in Amsterdam et al. (1995) or using the Trizol reagent (GIBCO BRL). Two pairs of primers, EGFP3/EGFP2 and v-GRHL/vasP3 were used to amplify a 415 bp fragment of the vas::EGFP transgene and a 310 bp fragment of the endogenous vas using the AmpliTaq PCR system (Perkin Elmer). After the initial denaturation step, the PCR parameters were 25 cycles at 968C for 30 s, 528C for 30 s, 688C for 1 min. The PCR products were analysed by agarose gel electrophoresis.
Fluorescence microscopy and imaging
Embryos were anaesthetised in the presence of Tricaine (Sigma) and examined using a Nikon inverted microscope equipped with a FITC filter (B-2A), or a TRITC filter (G-2A) and a digital camera.
